Evidence map›Paper›PMID 36405001›Full record

ArticleActa clinica Croatica2021

CORTICOSTEROIDS IN THE MANAGEMENT 
OF PEDIATRIC EPILEPSIES.

Igor Prpić, Ines Blažeković, Jelena Radić Nišević, Ivana Kolić

Abstract read
In one paragraph

Article in Acta clinica Croatica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Igor Prpić1Rijeka University Hospital Centre, Department of Pediatrics, Division of Child Neurology and Child Psychiatry, Referral Centre for Childhood Epilepsies and Convulsive Disorders, Rijeka, Croatia; 
2Faculty of Medicine, University of Rijeka, Rijeka, Croatia; 
3Faculty of Health Studies, University of Rijeka, Rijeka, Croatia.
Ines Blažeković1Rijeka University Hospital Centre, Department of Pediatrics, Division of Child Neurology and Child Psychiatry, Referral Centre for Childhood Epilepsies and Convulsive Disorders, Rijeka, Croatia; 
2Faculty of Medicine, University of Rijeka, Rijeka, Croatia; 
3Faculty of Health Studies, University of Rijeka, Rijeka, Croatia.
Jelena Radić Nišević1Rijeka University Hospital Centre, Department of Pediatrics, Division of Child Neurology and Child Psychiatry, Referral Centre for Childhood Epilepsies and Convulsive Disorders, Rijeka, Croatia; 
2Faculty of Medicine, University of Rijeka, Rijeka, Croatia; 
3Faculty of Health Studies, University of Rijeka, Rijeka, Croatia.
Ivana Kolić1Rijeka University Hospital Centre, Department of Pediatrics, Division of Child Neurology and Child Psychiatry, Referral Centre for Childhood Epilepsies and Convulsive Disorders, Rijeka, Croatia; 
2Faculty of Medicine, University of Rijeka, Rijeka, Croatia; 
3Faculty of Health Studies, University of Rijeka, Rijeka, Croatia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epilepsy is one of the most common chronic diseases in children, and cannot be controlled with conventional antiepileptic drugs in 30% of cases. Therefore, in these cases, alternative approach such as corticosteroid therapy (CT) is used. The aim of this study was to analyze different types of CT used to treat drug-resistant childhood epilepsies, treated at Rijeka University Hospital Centre during a 5-year period (2016-2020). This retrospective study included 32 patients. The following parameters were analyzed: number of patients with a particular diagnosis, average age (in months) at the onset of epilepsy, average epilepsy duration (in months) prior to CT, average number of antiepileptic drugs used prior to CT, presence of changes on magnetic resonance imaging (MRI), presence of comorbidities, and types of CT. The average age at the onset of epilepsy was 14 months and average epilepsy duration prior to CT was 16 months. On average, 5 antiepileptic drugs were used prior to CT. MRI changes were present in 53.13% and comorbidities in 81.25% of study patients. Prednisone therapy was used in 28.13%, combined therapy with prednisone and methylprednisolone in 65.63%, and methylprednisolone in 6.25% of patients. Study results revealed the use of CT for particular diagnosis to differ among the centers, as well as within the same center, so it is important to highlight the importance of reaching universal guidelines for CT therapy of childhood epilepsies.

Indexed as

AnticonvulsantsEpilepsyAdrenal Cortex HormonesChildHumansMethylprednisolonePrednisoneRetrospective StudiesAdrenal Cortex HormonesAnticonvulsantsMethylprednisolonePrednisoneCorticosteroidsEpilepsy, pharmacoresistantGuidelines

Identifiers

PMID36405001
PMCPMC9590238

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.